Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Hypertension
Interventions
DRUG

BMS-823778

Capsules, Oral, 2 mg, Once daily, 12 weeks

DRUG

BMS-823778

Capsules, Oral, 6 mg, Once daily, 12 weeks

DRUG

BMS-823778

Capsules, Oral, 15 mg, Once daily, 12 weeks

DRUG

Placebo matching with BMS-823778

Capsules, Oral, 0 mg, Once daily, 12 weeks

Trial Locations (35)

1125

Local Institution, Budapest

1133

Local Institution, Budapest

1134

Local Institution, Budapest

4026

Local Institution, Debrecen

20110

Manassas Clinical Research Center, Manassas

23294

National Clinical Research - Richmond, Inc., Richmond

23502

National Clinical Research - Norfolk, Inc., Norfolk

27103

Local Institution, Winston-Salem

27408

Pharmquest, Llc, Greensboro

28144

Pmg Research Of Salisbury, Salisbury

28150

Local Institution, Shelby

28152

Local Institution, Shelby

28204

Metrolina Internal Medicine, Charlotte

29615

Local Institution, Greenville

30303

Local Institution, Atlanta

33134

Local Institution, Coral Gables

45246

Sterling Research Grp, Ltd., Cincinnati

70115

Local Institution, New Orleans

72401

Nea Baptist Clinic, Jonesboro

84041

Local Institution, Layton

90057

Local Institution, Los Angeles

92262

Desert Medical Group Inc., Palm Springs

70808-4124

Pennington Biomedical Research Center, Baton Rouge

08817

Anderson And Collins Clinical Research, Inc., Edison

08611

Premier Research, Trenton

13202-3108

Syracuse Preventive Cardiology, Syracuse

Unknown

Local Institution, Barranquilla

Local Institution, Bucaramanga

Local Institution, Cartagena

Local Institution, Manizales

Local Institution, Medellín

H-8230

Local Institution, Balatonfüred

00717

Local Institution, Ponce

599 31

Local Institution, Ödeshög

141 86

Local Institution, Stockholm

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY